Opinion

Video

Type 2 Inflammatory Diseases and Impact on Quality of Life

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms and limitations in daily activities.

  • How do type 2 inflammatory diseases, such as asthma, eosinophilic esophagitis, or chronic rhinosinusitis with nasal polyps, impact patients’ quality of life?
  • What challenges do patients face in managing their type 2 inflammatory disease(s) on a daily basis?
  • Describe type 2 inflammation. What diseases beyond those mentioned above can it be associated with?
  • What causes this overactive inflammatory response? In your clinical practice, how often do you see patients with type 2 inflammation?
Related Videos
Susan Perlman, MD, an expert on Friedreich's ataxia
Susan Perlman, MD, an expert on Friedreich's ataxia
1 KOL is featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
Related Content
MG graphic | Image Credit: © Andrii-stock.adobe.com
October 2nd 2024

SC Efgartigimod Shows Noninferiority to IV Formulation in gMG

AJMC Contributor
The researchers have detailed their complete findings of subcutaneous (SC) vs intravenous (IV) efgartigimod in generalized myasthenia gravis (gMG) from the phase 3 ADAPT-SC trial and initial findings from the open-label extension of the study, ADAPT-SC+.
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Lucio N. Gordan, MD | Image credit: Florida Cancer Specialists & Research Institute
October 1st 2024

How Do Community Oncologists View the Use of MRD Testing?

Mary Caffrey
Investigators from Florida Cancer Specialists & Research Institute explored questions surrounding minimal residual disease (MRD) negativity testing in an abstract presented at the International Myeloma Society 21st Annual Meeting & Exposition.
Managed Care Cast
May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi
In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Definition of opioids | Image Credit: Feng Yu - stock.adobe.com
September 30th 2024

Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD

Brooke McCormick
A study found that opioid use, with or without benzodiazepines, significantly increases long-term mortality risk in patients with chronic obstructive pulmonary disease (COPD) over the age of 60 years.
National Ovarian Cancer Awareness Month | Image Credit: Rabin - stock.adobe.com
September 30th 2024

Ovarian Cancer Awareness Month: Prioritizing Early Detection, Bridging Equity Gaps

Brooke McCormick
September marked Ovarian Cancer Awareness Month, highlighting the importance of early detection and the need for equitable treatment access.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo